PE20020447A1 - Ligandos receptores de melanocortina - Google Patents
Ligandos receptores de melanocortinaInfo
- Publication number
- PE20020447A1 PE20020447A1 PE2001000965A PE2001000965A PE20020447A1 PE 20020447 A1 PE20020447 A1 PE 20020447A1 PE 2001000965 A PE2001000965 A PE 2001000965A PE 2001000965 A PE2001000965 A PE 2001000965A PE 20020447 A1 PE20020447 A1 PE 20020447A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- aryl
- halo
- heterocycle
- halves
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23585800P | 2000-09-27 | 2000-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20020447A1 true PE20020447A1 (es) | 2002-07-02 |
Family
ID=22887187
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000965A PE20020447A1 (es) | 2000-09-27 | 2001-09-27 | Ligandos receptores de melanocortina |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1409540A2 (fr) |
JP (1) | JP2004509974A (fr) |
KR (1) | KR100519204B1 (fr) |
CN (1) | CN1571796A (fr) |
AR (1) | AR030806A1 (fr) |
AU (2) | AU2001296313B2 (fr) |
BR (1) | BR0114257A (fr) |
CA (1) | CA2420045A1 (fr) |
CZ (1) | CZ2003788A3 (fr) |
HU (1) | HUP0303085A2 (fr) |
IL (1) | IL154437A0 (fr) |
MX (1) | MXPA03002691A (fr) |
NO (1) | NO20031287D0 (fr) |
NZ (1) | NZ524190A (fr) |
PE (1) | PE20020447A1 (fr) |
PL (1) | PL362003A1 (fr) |
RU (1) | RU2246501C2 (fr) |
WO (1) | WO2002026774A2 (fr) |
ZA (1) | ZA200301561B (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7176279B2 (en) | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
US7226755B1 (en) | 2002-09-25 | 2007-06-05 | The Procter & Gamble Company | HPTPbeta as a target in treatment of angiogenesis mediated disorders |
US7507568B2 (en) | 2002-09-25 | 2009-03-24 | The Proctor & Gamble Company | Three dimensional coordinates of HPTPbeta |
EP2368579A1 (fr) | 2004-01-21 | 2011-09-28 | Novo Nordisk Health Care AG | Conjugaison au moyen de transglutaminase de peptides |
RU2309144C2 (ru) * | 2005-03-25 | 2007-10-27 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств |
US8247530B2 (en) | 2005-11-08 | 2012-08-21 | Palatin Technologies, Inc. | N-alkylated cyclic peptide melanocortin agonists |
WO2007116360A2 (fr) | 2006-04-07 | 2007-10-18 | The Procter & Gamble Company | Anticorps se liant à la protéine tyrosine phosphatase bêta humaine (hptpbêta) et utilisations correspondantes |
RU2303597C1 (ru) * | 2006-05-12 | 2007-07-27 | Иващенко Андрей Александрович | Фармацевтическая композиция, способы ее получения и применения |
US7589212B2 (en) | 2006-06-27 | 2009-09-15 | Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
US8846685B2 (en) | 2006-06-27 | 2014-09-30 | Aerpio Therapeutics Inc. | Human protein tyrosine phosphatase inhibitors and methods of use |
US7795444B2 (en) | 2006-06-27 | 2010-09-14 | Warner Chilcott Company | Human protein tyrosine phosphatase inhibitors and methods of use |
US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
WO2008107362A2 (fr) * | 2007-03-07 | 2008-09-12 | Novo Nordisk Health Care Ag | Nouveaux inhibiteurs du facteur de coagulation sanguine |
WO2009152079A1 (fr) | 2008-06-09 | 2009-12-17 | Palatin Technologies, Inc. | Peptides spécifiques du récepteur de mélanocortine pour le traitement d'un dysfonctionnement sexuel |
US9096555B2 (en) | 2009-01-12 | 2015-08-04 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome |
WO2010144341A2 (fr) | 2009-06-08 | 2010-12-16 | Palatin Technologies, Inc. | Peptides spécifiques des récepteurs aux mélanocortines à pont lactame |
UY32690A (es) | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Péptidos específicos para receptores de melanocortina |
KR101726893B1 (ko) | 2009-06-08 | 2017-04-13 | 팔라틴 테크놀로지스 인코포레이티드 | 멜라노코르틴 수용체-특이적 펩티드 |
BRPI1006897A2 (pt) | 2009-07-06 | 2015-09-08 | Akebia Therapeutics Inc | compostos, composições e métodos de prevenção da metástase de células cancerosas. |
US8883832B2 (en) | 2009-07-06 | 2014-11-11 | Aerpio Therapeutics Inc. | Compounds, compositions, and methods for preventing metastasis of cancer cells |
WO2011060355A1 (fr) * | 2009-11-16 | 2011-05-19 | Ipsen Pharma S.A.S | Procede de synthese de ac-arg-cyclo(cys-d-ala-his-d-phe-arg-trp-cys)-nh2 |
MX2012005862A (es) | 2009-11-23 | 2012-09-07 | Palatin Technologies Inc | Peptidos ciclicos especificos del receptor de melanocortina-1. |
EP2504351A4 (fr) | 2009-11-23 | 2013-10-30 | Palatin Technologies Inc | Peptides linéaires spécifiques du récepteur de la mélanocortine-1 |
US10347423B2 (en) | 2014-05-12 | 2019-07-09 | Capacitor Sciences Incorporated | Solid multilayer structure as semiproduct for meta-capacitor |
US10340082B2 (en) | 2015-05-12 | 2019-07-02 | Capacitor Sciences Incorporated | Capacitor and method of production thereof |
KR102331588B1 (ko) | 2014-05-12 | 2021-11-30 | 캐패시터 사이언시스 인코포레이티드 | 에너지 저장 디바이스 및 이의 생산 방법 |
AU2015343211A1 (en) | 2014-11-04 | 2017-04-27 | Capacitor Sciences Incorporated | Energy storage devices and methods of production thereof |
KR20170118764A (ko) | 2015-02-26 | 2017-10-25 | 캐패시터 사이언시스 인코포레이티드 | 자기-회복 커패시터 및 이들의 생산 방법 |
US9932358B2 (en) * | 2015-05-21 | 2018-04-03 | Capacitor Science Incorporated | Energy storage molecular material, crystal dielectric layer and capacitor |
US9941051B2 (en) | 2015-06-26 | 2018-04-10 | Capactor Sciences Incorporated | Coiled capacitor |
US10026553B2 (en) | 2015-10-21 | 2018-07-17 | Capacitor Sciences Incorporated | Organic compound, crystal dielectric layer and capacitor |
US10305295B2 (en) | 2016-02-12 | 2019-05-28 | Capacitor Sciences Incorporated | Energy storage cell, capacitive energy storage module, and capacitive energy storage system |
US9978517B2 (en) | 2016-04-04 | 2018-05-22 | Capacitor Sciences Incorporated | Electro-polarizable compound and capacitor |
US10153087B2 (en) | 2016-04-04 | 2018-12-11 | Capacitor Sciences Incorporated | Electro-polarizable compound and capacitor |
US10395841B2 (en) | 2016-12-02 | 2019-08-27 | Capacitor Sciences Incorporated | Multilayered electrode and film energy storage device |
CN106966927B (zh) * | 2017-04-13 | 2018-10-09 | 菲立化学工程(上海)有限公司 | 一种抗艾滋病药物中间体重氮酮与氯酮的合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6350430B1 (en) * | 1997-10-27 | 2002-02-26 | Lion Bioscience Science Ag | Melanocortin receptor ligands and methods of using same |
KR100558131B1 (ko) * | 1999-03-29 | 2006-03-10 | 더 프록터 앤드 갬블 캄파니 | 멜라노코르틴 수용체 리간드를 함유하는 약제학적 조성물및 멜라노코르틴 수용체 리간드를 함유하는 약제의제조방법 |
US6579968B1 (en) * | 1999-06-29 | 2003-06-17 | Palatin Technologies, Inc. | Compositions and methods for treatment of sexual dysfunction |
-
2001
- 2001-09-26 JP JP2002531157A patent/JP2004509974A/ja active Pending
- 2001-09-26 MX MXPA03002691A patent/MXPA03002691A/es unknown
- 2001-09-26 AU AU2001296313A patent/AU2001296313B2/en not_active Ceased
- 2001-09-26 CA CA002420045A patent/CA2420045A1/fr not_active Abandoned
- 2001-09-26 CZ CZ2003788A patent/CZ2003788A3/cs unknown
- 2001-09-26 HU HU0303085A patent/HUP0303085A2/hu unknown
- 2001-09-26 RU RU2003112211/04A patent/RU2246501C2/ru not_active IP Right Cessation
- 2001-09-26 KR KR10-2003-7004415A patent/KR100519204B1/ko not_active IP Right Cessation
- 2001-09-26 BR BR0114257-7A patent/BR0114257A/pt not_active IP Right Cessation
- 2001-09-26 IL IL15443701A patent/IL154437A0/xx unknown
- 2001-09-26 CN CNA01816384XA patent/CN1571796A/zh active Pending
- 2001-09-26 AU AU9631301A patent/AU9631301A/xx active Pending
- 2001-09-26 PL PL36200301A patent/PL362003A1/xx not_active Application Discontinuation
- 2001-09-26 EP EP01977175A patent/EP1409540A2/fr not_active Withdrawn
- 2001-09-26 NZ NZ524190A patent/NZ524190A/en unknown
- 2001-09-26 WO PCT/US2001/030051 patent/WO2002026774A2/fr active IP Right Grant
- 2001-09-27 AR ARP010104557A patent/AR030806A1/es unknown
- 2001-09-27 PE PE2001000965A patent/PE20020447A1/es not_active Application Discontinuation
-
2003
- 2003-02-26 ZA ZA200301561A patent/ZA200301561B/en unknown
- 2003-03-20 NO NO20031287A patent/NO20031287D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR100519204B1 (ko) | 2005-10-06 |
AU2001296313B2 (en) | 2005-06-02 |
ZA200301561B (en) | 2004-03-10 |
HUP0303085A2 (hu) | 2003-12-29 |
NO20031287L (no) | 2003-03-20 |
RU2246501C2 (ru) | 2005-02-20 |
JP2004509974A (ja) | 2004-04-02 |
MXPA03002691A (es) | 2003-06-06 |
BR0114257A (pt) | 2003-07-01 |
IL154437A0 (en) | 2003-09-17 |
CN1571796A (zh) | 2005-01-26 |
PL362003A1 (en) | 2004-10-18 |
KR20030061814A (ko) | 2003-07-22 |
NZ524190A (en) | 2004-09-24 |
WO2002026774A2 (fr) | 2002-04-04 |
NO20031287D0 (no) | 2003-03-20 |
AU9631301A (en) | 2002-04-08 |
CZ2003788A3 (cs) | 2003-08-13 |
CA2420045A1 (fr) | 2002-04-04 |
AR030806A1 (es) | 2003-09-03 |
EP1409540A2 (fr) | 2004-04-21 |
WO2002026774A3 (fr) | 2003-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20020447A1 (es) | Ligandos receptores de melanocortina | |
PE20011083A1 (es) | 2-indolinas sustituidas con pirroles inhibidoras de proteinquinasas | |
CO5721000A2 (es) | (tiazol-2-il)-amida o sulfonamida substituida como activado- res de glicocinasa utiles en el tratamiento de diabetes de tipo 2 | |
CA2430978A1 (fr) | Inhibiteurs de vla-4 | |
DE69613240T2 (de) | N-aminoalkylfluorencarboxamide, neue klasse von dopaminerezeptor subtype spezifische liganden | |
CY1107679T1 (el) | Παραγωγα οξαζολυλ-αρυλ προπιονικου οξεος και χρηση αυτων σαν αγωνιστες ppar | |
CO5251458A1 (es) | Nuevos compuestos | |
GB9225492D0 (en) | Amine derivatives | |
DE69719765D1 (de) | 4-aminoethoxy-indolderivate als dopamin d2 agonisten und als 5ht1a liganden | |
TW200602317A (en) | Novel androgens | |
KR940014384A (ko) | 항바이러스제로서의 페녹시- 및 페녹시알킬-피페리딘 | |
TW197421B (fr) | ||
DE60008917D1 (de) | Neue 1,8-naphtyridin-2(1h)-on-derivate | |
PE20011137A1 (es) | Inhibidores de las metaloproteasas que contienen cadenas laterales heterociclicas n-sustituidas | |
DE69822478D1 (de) | Thiophen- und benzothiophenderivate, deren verwendung und sie enthaltende zubereitung | |
DK709088A (da) | Thiolderivater | |
JO2235B1 (en) | Derivatives of phenyl | |
EP1092737A3 (fr) | Composition d'un catalyseur pour la préparation d'une résine de polyuréthane et procédé pour la préparation d'une résine de polyuréthane | |
ATE207058T1 (de) | Amine derivate, ihre herstellung und anwendung | |
EP1604983A4 (fr) | Antagoniste de recepteur | |
EP1864977A4 (fr) | Nouveaux composes cycliques possedant un groupe pyrimidinylalkylthio | |
MY140027A (en) | Cyclic amine derivatives, process for their preparation and pharmaceuticals containing them | |
ATE188967T1 (de) | Übergangsmetallverbindungen | |
KR960022504A (ko) | 1-옥소-2-(페닐술포닐아미노) 펜틸피페리딘 유도체, 그것의 제법 및 치료학적 적용 | |
ATE227284T1 (de) | 4-aminoethoxy-indolonderivate als dopamin d2 agonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |